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accumulation in chloroplasts of eukaryotic 
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Abstract 
Eukaryotic green algae have become an increasingly popular platform for recombinant proteins production. In par‑
ticular, Chlamydomonas reinhardtii, has garnered increased attention for having the necessary biochemical machin‑
ery to produce vaccines, human antibodies and next generation cancer targeting immunotoxins. While it has been 
shown that chloroplasts contain chaperones, peptidyl prolylisomerases and protein disulfide isomerases that facilitate 
these complex proteins folding and assembly, little has been done to determine which processes serve as rate‑
limiting steps for protein accumulation. In other expression systems, as Escherichia coli, Chinese hamster ovary cells, 
and insect cells, recombinant protein accumulation can be hampered by cell’s inability to fold the target polypeptide 
into the native state, resulting in aggregation and degradation. To determine if chloroplasts’ ability to oxidize proteins 
that require disulfide bonds into a stable conformation is a rate‑limiting step of protein accumulation, three recom‑
binant strains, each expressing a different recombinant protein, were analyzed. These recombinant proteins included 
fluorescent GFP, a reporter containing no disulfide bonds; Gaussia princeps luciferase, a luminescent reporter contain‑
ing disulfide bonds; and an immunotoxin, an antibody‑fusion protein containing disulfide bonds. Each strain was 
analyzed for its ability to accumulate proteins when supplemented with selenocystamine, a small molecule capable 
of catalyzing the formation of disulfide bonds. Selenocystamine supplementation led to an increase in luciferase and 
immunotoxin but not GFP accumulation. These results demonstrated that selenocystamine can increase the accumu‑
lation of proteins containing disulfide bonds and suggests that a rate‑limiting step in chloroplast protein accumula‑
tion is the disulfide bonds formation in recombinant proteins native structure.
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Introduction
The advent of recombinant DNA technologies and the 
ability to transform microbial organisms with synthetic 
DNA has revolutionized the pharmaceutical industry 
(Walsh 2014). As a first demonstration, plasmid DNA 
encoding insulin chain A and B was introduced into 
Escherichia coli and shown to be capable of using the 
bacterial machinery to produce recombinant insulin 
for use in patients, albeit at poor yield (Johnson 1983). 
Since that time, many expression platforms have been 
developed to harness the unique characteristics of each 
protein. In instances where post-translational modifica-
tions are required, the expression systems of choice are 
Chinese hamster ovary (CHO) cells, insect cells, or the 
methylotrophic yeast, Pichia pastoris (Ahmad et al. 2014; 
Kim et al. 2012; Vrljic et al. 2011). When relatively large 
quantities of simple proteins lacking post-translational 
modifications are required, E. coli is the system of choice 
(Rosano and Ceccarelli 2014). Since their introduction, 
each expression system has been examined in detail to 
determine which factors facilitate protein folding and 
also to identify the rate-limiting steps of protein produc-
tion (Sato and Inaba 2012). Once identified, it has been 
possible to modify the host organism or growth param-
eters to overcome these rate-limiting steps in order to 
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increase recombinant protein accumulation (Lilie et  al. 
1994; Sato and Inaba 2012; Horwich et al. 1999).
Recently, eukaryotic green microalgae have been 
explored as a potential protein production platform. 
Algae offer attractive production features, including pho-
tosynthetic growth (Franklin and Mayfield 2004), ease 
of genetic manipulations (Grossman 2000), and unique 
biochemical compartments (Tran et  al. 2009). These 
features allow green algae to produce complex heter-
ologous proteins at a fraction of the cost of traditional 
protein expression platforms (Franklin and Mayfield 
2004). Additionally, many green algae are edible, open-
ing up the possibility of orally delivering bioactive pro-
teins and removing cumbersome and costly downstream 
purifications associated with other expression systems 
(Barrera et  al. 2014; Gregory et  al. 2012). In particular, 
Chlamydomonas reinhardtii has had a full repertoire 
of genetic tools developed that allow for integration of 
foreign genes into the mitochondrial, nuclear and chlo-
roplast genomes (Popescu and Lee 2007; Specht et  al. 
2010). C. reinhardtii has also been used to demonstrate 
the ability of chloroplasts to facilitate the production of 
full-length human antibodies (Tran et al. 2013b), indus-
trial enzymes (Rasala et al. 2012), and vaccine molecules 
(Gregory et  al. 2012). In some instances, C. reinhardtii 
chloroplasts were capable of accumulating large quanti-
ties of recombinant proteins (Manuell et al. 2007). How-
ever, when producing more complex proteins, such as 
full-length human antibodies and immunotoxins, the 
accumulation levels are relatively low, typically below 
1% of total soluble protein (TSP) (Tran et  al. 2013b). 
Although chloroplasts have the machinery to produce 
and assemble these complex proteins with multiple 
disulfide bonds (Tran et al. 2013a, b), little has been done 
to determine which steps of complex protein accumula-
tion are rate-limiting.
Chlamydomonas reinhardtii chloroplasts contain 
chaperones (Schroda 2004), peptidyl propylisomerases 
(PPIases) (Breiman et  al. 1992) and protein disulfide 
isomerases (PDIs) (Levitan et  al. 2005) that are each 
responsible for catalyzing an important step in the accu-
mulation of complex disulfide bond-containing proteins 
(Tran et  al. 2013b). When disulfide bonds of heterolo-
gous proteins are formed incorrectly, aggregation can 
occur, which ultimately leads to degradation of the mis-
folded polypeptide to prevent damage to the host expres-
sion organism (Sato and Inaba 2012; Schroder 2008). In 
C. reinhardtii, the PDIs could serve dual functions both 
as translational activators (Kim and Mayfield 1997) and 
as enzymes responsible for catalyzing the formation of 
disulfide bonds (Wilkinson and Gilbert 2004; Levitan 
et al. 2005). This dual responsibility of PDIs can poten-
tially limit the capacity of C. reinhardtii to fold, assemble 
and accumulate complex proteins containing large num-
bers of disulfide bonds. To determine if the formation of 
disulfide bonds is a rate-limiting step in the accumula-
tion of heterologous proteins in C. reinhardtii chloro-
plasts, we used the ability of small molecule diselenides 
to catalyze oxidative protein folding to interrogate pro-
tein accumulation in the algal chloroplast. Previously, it 
was shown that these small molecule diselenides were 
able to assist in oxidative protein folding in vitro and in 
E. coli (Beld et al. 2010). Although diselenide bonds are 
intrinsically stronger than disulfide bonds, the folding 
energy of the protein upon formation of disulfide bonds, 
is sufficient to break small molecule diselenide bonds. 
The formed free selenols are efficient disulfide shuffling 
reagents and the presence of oxygen recycles quickly the 
diselenides, and thus these reagents are catalytic. In vivo, 
it remains the question with which small molecule and 
protein thiols and disulfides these diselenide reagents 
interact (Beld et  al. 2007;  Hondal et  al. 2013; Nauser 
et al. 2012). E. coli does not harbor PDI but relies on a 
separate oxidase DsbA and isomerase DsbC to introduce 
and reshuffle proteinogenic disulfide bonds. In a DsbA-
knockout background, selenocystamine proved to be an 
especially efficient catalyst of oxidative protein folding. 
Here we applied a similar technique to shine light on the 
ability of C. reinhardtii chloroplasts to accumulate pro-
teins containing disulfides.
For this study, we used recombinant strain of algae 
expressing Gaussia princeps luciferase that require 
the formation of disulfide bonds for biological activ-
ity (Goerke et  al. 2008; Tran et  al. 2013b), and we also 
expressed green fluorescent protein (GFP), which does 
not contain or require disulfide bonds for activity (Prisco 
et  al. 2005). Both recombinant strains were grown in 
the presence or absence of selenocystamine. Each strain 
was carefully monitored and analyzed to determine if 
selenocystamine could increase recombinant protein 
expression. To test another protein with potential for 
commercial application, recombinant strain expressing 
an immunotoxin (complex therapeutic protein contain-
ing disulfide bonds), was also grown in the absence or 
presence of cystamine or selenocystamine at 2 µM. These 
results helped decipher the rate-limiting steps of protein 
accumulation C. reinhardtii chloroplast, and by these 
findings, we will be able to target improvements in the 
algal expression platform that can lead to the develop-
ment of a robust microalgal expression platform.
Materials and methods
Chlamydomonas reinhardtii strains
Chlamydomonas reinhardtii strain, termed w1.1, is a 
genetically modified, non-photosynthetic expressing 
serum amyloid A (SAA) in the psbA site (Manuell et al. 
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2007). This strain was transformed to obtain the recom-
binant strains used in this paper and as a control for all 
the cultivations. The chloroplasts were transformed 
such that the psbA site was replaced with genes encod-
ing for GFP or luciferase (Gluc) (Figure  1a), generating 
the respective strains: CC-5117 psbA::pGFP mt+ and 
CC-5118 psbA::pGluc mt+. The recombinant strain 
expressing immunotoxin (αCD22HCH23PE40) was pre-
viously engineered using the same vector (Figure  1a) 
(Tran et al. 2013b).
Plasmid construction
All plasmids were constructed to be transformed into 
C. reinhardtii chloroplasts, and for this reason, all genes 
were codon optimized to contain adenine and uracil 
nucleotides in the third position, favoring codons with 
guanine and cytosine (Nakamura et al. 1999). Two differ-
ent plasmids were constructed—one encoding GFP from 
Aequorea victoria (pGFP—deposit number at Addgene: 
64904) and one encoding Gluc, which contains the lucif-
erase gene from Gaussia princeps (pGluc).
Figure 1 DNA gene constructs, site of integration and identification of transformants in Chlamydomonas reinhardtii chloroplast. a Transforma‑
tion vector containing the genes of interest: Gluc (Luciferase from Gaussia princeps), or GFP (Green Fluorescent Protein from Aequorea vcitoria), or 
Immunotoxin (αCD22CH23PE40 (Tran et al. 2013b)). Regions of the chloroplast genome were positioned at both ends of the transformation vector 
to allow homologous integration of the whole transformation cassette into the chloroplast genome (w1.1). b, c Colony PCR amplification to confirm 
the presence of recombinant genes of interest, Gluc—Luciferase from Gaussia princeps (b) or GFP—Green Fluorescent Protein (c). b, c Lanes 1, 2 
and 3 show three different gene positive colonies (dotted arrow). d, e Colony PCR amplification to check homoplasmicity by using primers from the 
genome to verify the absence of the second band (dashed arrow), which indicates the replacement of SAA by our recombinant genes. The black 
arrow shows the amplified control PCR product. d, e Lanes 1 and 3 show homoplasmic colonies, and lane 2 a control. All the arrows (dotted, dashed 
and black) are also marked (a) to indicate the gene amplified regions.
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Both genes of interest were designed with restriction 
site NdeI at the 5′ end and XbaI at the 3′ end, immedi-
ately outside of the coding region to facilitate subsequent 
cloning. Genes were ligated into the psbA transformation 
vector (Tran and Mayfield 2010), which contains a kana-
mycin gene (aphA6) as selection marker (Figure 1a).
Chlamydomonas reinhardtii strain transformation
Chlamydomonas reinhardtii w1.1 strain was grown 
in tris-acetate-phosphate (TAP) (Gorman and Lev-
ine 1965) liquid medium at 23°C, on rotary shaker set 
at 100  rpm, under constant light intensity (100  µmol 
photons m−2  s−1) provided by fluorescent lamps over 
3  days, to a cell concentration between 8  ×  105 and 
2 ×  106  cells  mL−1. Cells were harvested by centrifuga-
tion (2,500  rpm/1,200g) and about 1.0 ×  107 cells were 
plated on TAP agar containing 100 µg mL−1 of kanamy-
cin. After drying, these cells were transformed by parti-
cle bombardment (Boynton et al. 1988). Briefly, 550 nm 
diameter gold particles (S550d Seashell Technologies, 
San Diego) covered with 10 µg of plasmid DNA were shot 
using the gun at a distance of 4 cm at 375 psi.
After 1  week, transformed colonies selected on TAP 
agar plates containing 100  µg  mL−1 of kanamycin were 
patched onto TAP plates containing 150 µg mL−1 of kan-
amycin. Screening for the presence of genes was done by 
colony PCR using cell lysate (95°C during 10  min) and 
promoter-specific (psbA) forward primers and gene-
specific reverse primers (Figure  1b, c). Homoplasmic-
ity was analyzed by PCR, using the following primers: 
5′-GCTTGAATTTATAAATTAAAATATTTTTAC-3′ 
and 5′-TTCTCTAGCGTTACTGATTACTTTA-3′ for 
verification of SAA loss at psbA site (w1.1) and primers 
5′-CCGAACTGAGGTTGGGTTTA-3′ and 5′-GGGG-
GAGCGAATAGGATTAG-3′ for verification of the 
coding region 16S rRNA presence as positive control 
(Figure 1d, e).
Oxidative molecules supplementation experiments
Selenocystamine and cystamine, diselenide and disulfide 
molecules, respectively, were fed to Chlamydomonas 
reinhardtii cultures. Selenocystamine was synthesized 
following a published procedure (Krief et  al. 2004), dis-
solved in 10 mM HCl, aliquoted, and stored at −20°C.
Inoculum for both recombinant strains was grown in 
TAP liquid medium from TAP agar, under light condi-
tions (100  µmol photons m−2  s−1) on a rotary shaker 
(100  rpm), at 23°C over 3  days, when log phase was 
achieved. Cells were inoculated in a 250 mL Erlenmeyer 
flask containing 100 mL liquid TAP using an initial cell 
concentration of 5  ×  104  cells  mL−1, and these were 
kept in the dark for 96 h. Afterward, flasks were placed 
under light conditions (100 µmol photons m−2 s−1), and 
this was considered time 0  h of cultivation, when sele-
nocystamine was added. Experiments were performed 
in triplicate. Selenocystamine (500  mM stock solution) 
was diluted in Hypure water and added to each experi-
ment in order to obtain the following final concentra-
tions evaluated in this work: 0.0, 0.1, 1.0, 2.0, 5.0, 10.0, 
25.0, 100.0  µM. Samples were withdrawn at 0, 8, 24, 
48, 72 and 96  h to measure cell concentration, fluores-
cence (GFP) and luminescence (Gluc). The cultures of 
the strain expressing αCD22CH23PE40 (immunotoxin) 
were fed with cystamine (500 mM stock solution, diluted 
in water) or selenocystamine at 2.0  µM, their samples 
collected after 48 h and the protein expression evaluated 
by ELISA.
Luminescence assay
Coelenterazine (Fisher Scientific, USA), substrate for 
Gluc, was dissolved in ethanol to obtain a 1  mM stock 
solution (Shao and Bock 2008). To assay luciferase activ-
ity, triplicates of culture samples were centrifuged at 
3,000  rpm (2,000g) for 10  min and sonicated in lysis 
buffer (TBST—500 mM Tris, 1.5 M NaCl and 0.1% tween 
20) at 15% amplitude for 15  s (two times each sample). 
The supernatant (soluble protein fraction) was isolated 
by centrifugation at 13,200  rpm (16,100g) for 10  min, 
and the protein concentration was quantified by LOWRY 
assay (Lowry et  al. 1951) to have the same volume and 
total protein concentration for each analysis. Immedi-
ately before luminescence analysis, a mixture of coe-
lenterazine and buffer [0.1  M K2HPO4 (pH 7.6), 0.5  M 
NaCl, 1  mM EDTA] at the ratio 1:50 (volume:volume) 
was added at the top of the culture by the injector of 
an Infinite M200 PRO plate reader (Tecan, Männedorf, 
Switzerland), which added 50  µL of substrate, followed 
by shaking for 3 s, waiting for 10 s, reading at automatic 
attenuation, with integration time of 1,000  ms and set-
tle time of 150 ms. Gluc luminescence is linear related to 
substrate (coelenterazine) concentration between 0.1 and 
10  µM (Wille et  al. 2012); for this reason, in all experi-
ments, substrate was added in excess to guarantee that all 
the enzyme was catalyzing the reaction to produce light 
for all the experiments. All coelenterazine solutions were 
kept at −20°C, and working solutions were kept on ice 
and in the dark.
Fluorescence assay
Triplicate culture samples (100  µL) were transferred 
directly to wells of a 96-well black plate, which was read 
using an Infinite M200 PRO plate reader (Tecan, Männe-
dorf, Switzerland). Fluorescence measurements were 
taken at 488/522 excitation/emission and TAP medium 
was used as blank. All the results of fluorescence were 
normalized to cell concentration (cells mL−1).
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ELISA assay
ELISA antigen binding assays were performed in 96-well 
microtiter plates (Costar, Corning, NY, USA), which 
were coated with 50  µL of 10  ng  µL−1 of total protein 
obtained from experiments carried out with the strain 
expressing αCD22CH23PE40 immunotoxin proteins. 
Plates were blocked with TBS buffer containing 1% 
bovine serum albumin (BSA). Wells were washed three 
times with 250 µL of TBS and primary antibody (ETA—
exotoxin A) was added at a concentration of 1:5,000 
(antibody:blocking buffer). After a washing step, second-
ary HRP (horseradish peroxidase) conjugated antibody 
was applied at the concentration (1:10,000). Peroxide 
solution (H2O2) and peroxidase substrate (TMB, Pierce) 
were premixed and 100 µL of this solution was added to 
each well, followed by 100  µL of a 2  M H2SO4 solution 
to stop the reaction. The plates were visualized at 450 nm 
and binding was quantified by color using a Spectra Max 
250 plate reader.
A calibration curve was carried out for each ELISA 
plate, by diluting samples of purified αCD22CH23PE40 
immunotoxin protein (Tran et  al. 2013b) with a control 
strain, to have four different expression percentages: 0.0, 
0.5, 1.0 and 5.0, which corresponds to: 0.0, 0.05, 0.10, 
0.5 mg mL−1 of purified immunotoxin, respectively.
Results
Plasmids constructions and chloroplast transformations
Chlamydomonas reinhardtii w1.1 strain was genetically 
transformed by particle bombardment and the recombi-
nant genes, in transformation vectors containing kana-
mycin resistance gene, were inserted into the psbA site 
of the chloroplast genome (Figure 1a). PCR of cell lysates 
was performed to verify the presence of Gluc or GFP 
(Figure 1b, c). Subsequently, gene positives were screened 
for homoplasmicity to guarantee that all copies of the 
chloroplast genome did not contain the SAA gene that 
will be replaced (Figure 1d, e).
Cell growth
A cell growth comparison was made between the two 
recombinant strains GFP and Gluc. The cell concen-
tration was measured for all the cultivations in the 
absence or presence of increasing selenocystamine 
final concentrations (0.0, 0.1, 1.0, 2.0, 5.0, 10.0, 25.0 and 
100.0 µM) during 96 h at the time points 0, 8, 24, 48, 72 
and 96 h.
During the experiments 0.1, 1.0 and 2.0  µM seleno-
cystamine concentrations, cell growth remained similar 
to the control cultivation that had no selenocystamine 
addition, without a lag phase at the beginning of the cul-
tivation. In both strains, Gluc and GFP were not affected 
by the addition of 5.0 µM selenocystamine, however in 
some cases a yellowish color (indicative of unhealthy 
cells) was observed after 24 h of cultivation, when com-
pared to the lower concentrations of selenocystamine 
(data not shown). Growth curves of strains expressing 
Gluc and GFP (Figure 2a, b) for the experiments 10, 25 
or 100  µM selenocystamine concentrations showed 
greatly reduced cell concentration compared to the 
other experiments. Cell concentration values for those 
three highest selenocystamine concentration experi-
ments decreased after 24  h, and cells were dead before 
the end of cultivation.
Gluc (Gaussia luciferase) luminescence assay
Gluc, strain expressing luciferase from Gaussia prin-
ceps, was cultivated in the absence or presence of sele-
nocystamine increasing concentrations (0.0, 0.1, 1.0, 2.0, 
5.0, 10.0, 25.0 and 100.0  µM). Gluc luminescence was 
Figure 2 Growth curves of recombinant Chlamydomonas reinhardtii 
strains cultivations treated with increasing concentrations of sele‑
nocystamine. a Cell concentration (cells mL−1) as a function of time 
(h), for recombinant C. reinhardtii—Gluc (strain expressing Gaussia 
luciferase) cultivations containing: 0.0, 0.1, 1.0, 2.0, 5.0, 10.0, 25.0 and 
100.0 µM selenocystamine final concentration in the culture medium, 
compared to control w1.1 (psbA knockout). b Cell concentration 
(cells mL−1) as a function of time (h), for recombinant C. reinhardtii—
GFP (strain expressing green fluorescent protein) cultivations contain‑
ing: 0.0, 0.1, 1.0, 2.0, 5.0, 10.0, 25.0 and 100.0 µM selenocystamine 
final concentration in the culture medium, compared to control w1.1 
(psbA knockout). Error bars were calculated from triplicate average 
values of three different experiments.
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analyzed for every time point and compared to the con-
trol strain (w1.1).
At time zero (Figure 3a), as expected, no effect on lumi-
nescence was detected in any treatment sample. After 8 h 
we found that higher selenocystamine concentrations 
resulted in higher luminescence levels, except in the 
experiments 25 and 100  µM selenocystamine con-
centrations, where luminescence appeared to be sig-
nificantly lower (Figure  3b). After 24  h (Figure  3c), the 
luminescence value was significantly higher for 2.0  µM 
Figure 3 Luminescence of recombinant C. reinhardtii—Gluc (strain expressing Gaussia luciferase protein) cultivations supplemented with seleno‑
cystamine. This oxidative molecule was supplemented to obtain the following final concentrations: 0.0, 0.1, 1.0, 2.0, 5.0, 10.0, 25.0 and 100.0 µM, and 
these were compared to control w1.1. a 0 h of cultivation; b 8 h; c 24 h; d 48 h; e 72 h; f 96 h. All error bars were calculated by using the triplicate 
average values of different experiments, and the values were equalized to total protein concentration.
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selenocystamine compared to the control. At 48  h of 
cultivation, the luminescence values were the highest 
compared to the other time points. At 72 and 96  h the 
luminescence values started to decrease compared to the 
earlier time points (Figure 3d–f).
GFP fluorescence assay
The recombinant strain expressing GFP in the chloro-
plast was cultivated in the absence or presence of sele-
nocystamine increasing concentrations (0.0, 0.1, 1.0, 2.0, 
5.0, 10.0, 25.0 and 100.0 µM). GFP relative fluorescence 
was analyzed for every time point and compared to the 
control strain (w1.1).
The experiments with lower selenocystamine concen-
trations (0.1, 1.0, 2.0 and 5.0 µM) showed no impact on 
GFP fluorescence, while high concentrations (10.0, 25.0 
and 100.0  µM) showed decreasing fluorescence signal. 
At time zero (Figure 4a), before flasks were placed under 
light growth conditions, relative fluorescence unit (RFU) 
values were the same across all experimental conditions. 
After 8 h (Figure 4b), a significant decrease in RFU val-
ues was observed in experiments with 25.0 and 100.0 µM 
selenocystamine. After 24 and 48  h of cultivation, 0, 
0.1, 1.0 and 2.0  µM selenocystamine additions showed 
very similar fluorescence values (Figure  4c, d), while in 
the experiments 5.0, 10.0, 25.0 and 100.0 µM selenocys-
tamine concentrations, lower RFU values were observed. 
At 72 and 96  h (Figure  4e, f ), RFU values were much 
lower than the other time points and at the same level 
between the experiments.
Immunotoxin αCD22CH23PE40 ELISA
The recombinant strain expressing the immunotoxin 
αCD22CH23PE40 was cultivated in the absence or 
presence of selenocystamine or cystamine at the con-
centration of 2.0  µM. Samples were taken after 48  h of 
cultivation, and an ELISA was carried out to compare 
the accumulation percentage between the diselenide or 
disulfide supplementation. The results of ELISA indicate 
that cells accumulated more immunotoxin protein when 
selenocystamine molecule was added to the cultivation 
media when compared to cystamine and to the control 
(Figure 5a). The calibration curve presented in Figure 5b 
was used to obtain the immunotoxin accumulation per-
centages and to compare different experiments.
Discussion
In this work we set out to evaluate the ability of a small 
molecule oxidant, selenocystamine, to increase protein 
accumulation of heterologous proteins that require the 
formation of disulfide bonds in algal chloroplasts. Chlo-
roplasts of C. reinhardtii were transformed with genes 
coding for Gluc (Goerke et al. 2008) that require disulfide 
bonds to be active, or GFP (Prisco et al. 2005) that does 
not. Stable strains expressing each of the genes were gen-
erated and cultured in the absence or presence of seleno-
cystamine increasing concentrations. Subsequently, their 
heterologous protein content was quantified to deter-
mine if selenocystamine had an effect on protein activ-
ity. When analyzed, it was demonstrated that only the 
strain expressing protein that contains disulfide bonds, 
Gluc, showed an increase in this heterologous protein. 
The increase of Gluc luminescence when compared to 
the control evidences the higher Gluc activity, which is 
correlated to the increase of disulfide bonds formation 
(Goerke et al. 2008). In contrast, when selenocystamine 
was fed to a strain containing GFP, a reporter protein 
that requires no disulfide bonds for activity, there was 
no significant change in protein accumulation that was 
observed. The best concentration of selenocystamine for 
Gluc activity increase was the chosen one to evaluate the 
effect of cystamine and selenocystamine, small oxidative 
molecules, on a stable strain expressing a more complex 
protein, immunotoxin (Tran et  al. 2013b). The strain 
expressing this complex therapeutic protein, containing 
12 disulfide bonds, also showed an increase of the recom-
binant protein accumulation.
Selenocystamine is a small molecule diselenide known 
for its ability to increase the rate of oxidative protein fold-
ing to allow proteins to achieve their native state (Beld 
et  al. 2010). Here we have presented data that demon-
strates selenocystamine has an impact on increase of 
recombinant protein in algal chloroplast when this pro-
tein requires the formation of disulfide bonds for biologi-
cal activity. Redox potential and the transfer of electrons 
plays a key role in chloroplast metabolism during photo-
synthesis (Johnson and Alric 2013) and translation (Tre-
bitsh et al. 2000). During photosynthesis, redox potential 
is generated through the transfer of an electron through 
the photosynthetic core apparatus. This redox poten-
tial is used to fix carbon dioxide into a storable energy 
source. Additionally, the reducing potential generated 
by photosynthesis has been shown to initiate a chain of 
redox reactions ultimately leading to the reduction of a 
nuclear-encoded protein, RB60 that initiates translation 
of genes under the control of the regulatory elements 
of the psbA 5′-UTR. With these pivotal roles that redox 
plays it could be possible for selenocystamine to have a 
universal impact on protein accumulation through pro-
cesses such as redox regulated translational activation or 
a limited role by stabilizing proteins that require disulfide 
bonds (Kim and Mayfield 1997). No increases were seen 
in GFP accumulation, suggesting that selenocystamine 
plays a role in stabilizing protein structures through the 
formation of disulfide bonds and potentially mitigat-
ing degradation of un-folded polypeptides. Although 
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selenocystamine was able to increase protein accumula-
tion, at concentrations greater than 5 µM, it became toxic 
to C. reinhardtii cultures. A similar toxicity was observed 
in Saccharomyces cerevisiae (Beld 2009). This toxicity is 
not unique to selenocystamine but appears to be a gen-
eral effect of oxidizing molecules such as glutathione 
Figure 4 Fluorescence of recombinant C. reinhardtii—GFP (strain expressing green fluorescent protein) cultivations supplemented with seleno‑
cystamine. This oxidative molecule was supplemented to obtain the following final concentrations: 0.0, 0.1, 1.0, 2.0, 5.0, 10.0, 25.0 and 100.0 µM, 
and these were compared to control w1.1. a 0 h of cultivation; b 8 h; c 24 h; d 48 h; e 72 h; f 96 h. RFU relative fluorescence unit. All error bars were 
calculated by using the triplicate average values, which were also equalized to cell concentration measurements.
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or 5,5′-dithiobis[2-nitrobenzoic acid] (Wakabayashi 
and King 2006) which caused C. reinhardtii cells to lose 
motility. Interestingly, when tested in S. cerevisiae, sele-
nocystamine did not significantly increase protein accu-
mulation of proteins containing disulfide bonds. This 
data suggest that C. reinhardtii is more efficient in sele-
nocystamine uptake into its chloroplast than S. cerevisiae 
cultures. It should also be noted that concentrations of 
selenocystamine that were able to increase recombinant 
active protein containing disulfide bonds in C. reinhardtii 
chloroplasts were similar to the concentrations that were 
observed to impact protein accumulation in E. coli cul-
tures (Beld et al. 2010).
Increasing the number of disulfide bonds in a protein 
generally increases the difficulty for a cell to achieve a sta-
ble conformation of the protein product. This inefficiency 
will lead to degraded protein and an overall decrease in 
accumulation. To determine if cystamine or selenocys-
tamine could impact the accumulation of a protein that 
has potential therapeutic relevance, these molecules were 
added to C. reinhardtii cultures expressing an immuno-
toxin with 12 disulfide bonds. Immunotoxin expressed in 
C. reinhardtii chloroplasts by Tran et  al. (2013b), binds 
target B-cells and kills them, making these proteins 
potential cancer therapies. Using the concentration of 
selenocystamine that had the greatest impact on Gluc 
accumulation (2.0 µM), we fed both oxidative molecules 
(cystamine or selenocystamine) to cultures expressing 
the immunotoxin (αCD22HCH23PE40) and detected 
a doubling of accumulation of immunotoxin proteins, 
when selenocystamine was fed. These result could be 
explained by the fact that diselenides (selenocystamine) 
are much stronger electrophile than disulfides (cysta-
mine), and also, the rate of selenol/diselenide exchange is 
much faster than the corresponding rate of thiol/disulfide 
exchange (Hondal et al. 2013; Pleasants et al. 1989). Thus, 
the action of selenocystamine, unlike cystamine, shows 
to positively impact protein accumulation in proteins 
that require the formation of many disulfide bonds to 
achieve a stable conformation.
Our results demonstrate that a small molecule disele-
nide can improve the heterologous accumulation and 
activity of proteins containing disulfide bonds in C. rein-
hardtii chloroplast, whereas proteins without disulfide 
bonds shows no apparent increase in yield. These find-
ings imply that limitations in oxidative protein folding 
are indeed partially responsible for lower yields of pro-
teins containing disulfide bonds like the immunotoxin. 
Similar to protein expression in bacteria, there is a clearly 
need for engineered algal strains with optimized oxida-
tive protein folding. Strategies such as the introduction 
of proteins that assist with oxidative protein folding, such 
as chaperones and PDIs, could dramatically increase 
the yields of these complex proteins in a scalable man-
ner. Overall, algal protein expression is coming of age, 
and with it the tools and understanding required to 
develop an optimal algal strain for heterologous protein 
expression.
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Figure 5 Immunotoxin (αCD22CH23PE40) expression in Chla-
mydomonas reinhardtii chloroplast. a The bar graph shows the 
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